pre-seed
Stage
2
Investors
About
Confluence Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and mitochondrial diseases.
Explore Confluence Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.